Pulmonx
LUNG
115 hedge funds and large institutions have $444M invested in Pulmonx in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 9 closing their positions.
8,814% more call options, than puts
Call options by funds: $2.58M | Put options by funds: $29K
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
41% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 29
14% more capital invested
Capital invested by funds: $388M → $444M (+$56M)
13% more funds holding
Funds holding: 102 → 115 (+13)
2.46% less ownership
Funds ownership: 92.18% → 89.72% (-2.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$12M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.14M |
| 3 |
Millennium Management
New York
|
+$7.08M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.97M |
| 5 |
BlackRock
New York
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$16.4M |
| 2 |
Morgan Stanley
New York
|
-$7.84M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.22M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$7.07M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$5.71M |
LUNG Hedge Fund Activity: Q2 2023 in Review
115 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2023, worth a combined $444M — up 14% from $388M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LUNG positions and 9 closed out — a net gain of 13 holders — while 41 added to existing stakes and 29 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $12M. The largest seller was Deerfield Management, cutting an estimated $16.4M.
- 115 institutional investors held Pulmonx (LUNG) as of Q2 2023, up from 102 in Q1 2023.
- Funds reported $444M of Pulmonx stock for Q2 2023, up 14% quarter-over-quarter.
- 22 funds opened new Pulmonx positions in Q2 2023 and 9 closed out, a net change of +13 holders.
- The largest Pulmonx buyer in Q2 2023 was Victory Capital Management, an estimated $12M added.
- The largest Pulmonx seller in Q2 2023 was Deerfield Management, an estimated $16.4M sold.
Based on aggregated 13F filings for Q2 2023.